SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SABRATEK CORP (SBTK)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LTK007 who wrote (160)6/17/1999 8:58:00 AM
From: Pluvia  Read Replies (2) of 487
 
***900,000 SBTK SHARES TO HIT THE MARKET***

8k Filed 6/16/99 indicates the SBTK LifeWatch purchase is $12.26 Million CASH, and 900,000 shares of stock which are available to sell beginning immediately upon registration by SBTK.

Bad News

1. If the sale of the 900,000 SBTK shares nets an average cost of less than $17.78 SBTK must make up the difference in cash.

2. If SBTK's auditor pulls their opinion and SBTK stock is halted SBTK could potentially lose an enormous amount of money on this deal as the stock price will likely be below $10.

3. SBTK's insurance may not cover a loss from the class action suit if SBTK management are deemed to have committed fraud. If true, that would mean SBTK may have to pay out of pocket - perhaps bankrupting SBTK.

BUYER BEWARE...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext